Company intelligence / Profile preview

AstaReal

Moses Lake, Washington, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

AstaReal’s proprietary natural astaxanthin products have been clinically tested in over 80 human studies, showing benefits across muscle endurance, skin health, anti-aging, eye and cardiovascular health, immune and gastric health. The compounds are marketed as premium ingredients in dietary supplements, cosmetics, and functional foods

Therapeutic areas: ImmunologyCardiovascularOphthalmologyGastroenterologyNeurologyOtherDermatology
Modalities: ProteinSmall molecule
Industry: Food & Nutrition

Partnerships

None listed with pharma/biotech majors; partnerships are mainly with nutraceutical, supplement, and food brands

Beyond the preview

Go deeper on AstaReal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AstaReal.

Explore the full profile